Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 1.30% today. In the last week its performance is 1.20%, and 7.08% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 71.28, so today’s gain of 1.30% is a significant step towards its target price. The GAP today is therefore 0.33%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 104521.46, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.90%.
At the current price of 64.1, it has a dividend yield of 3.56%, and its target price is 71.28. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.38, as well as a forward P/E of 11.32.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 17.71%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.25%.
Performance for the year is 15.31%. Since its IPO date on 1/2/2013, the total performance to date is 11.36%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 7451200, while its average volume is 7162.08. Whilst the total gain today was 1.30%, it did have a day high of -5.90%.
Volatility for this week has been at 1.35%, and 1.49% for the month. The 52-week low for AbbVie Inc., ABBV has been 45.15%, while the 52-week-high has reached -5.90%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.13, and the P/S is 4.22, along with a P/B of 18.47. Meanwhile it has a p/cash of 13.06.